Diagnosing asthma in adults requires both a characteristic pattern of symptoms and objective test results confirming that your airways narrow and open in a variable, reversible way. No single test confirms asthma on its own. Instead, your doctor pieces together your medical history, breathing tests, and sometimes blood work or specialized challenges to build the diagnosis and rule out other conditions that mimic it.
What Your Doctor Asks About First
The diagnostic process starts with a detailed conversation about your symptoms. The questions are designed to identify patterns that are distinctly “asthma-like” rather than pointing to another lung or heart condition. Expect to be asked whether you’ve experienced recurring episodes of coughing, wheezing, chest tightness, or shortness of breath over the past 12 months, and whether those episodes come and go rather than being constant.
Timing matters a lot. Symptoms that wake you at night or hit hardest in the early morning strongly suggest asthma, because airways naturally narrow during sleep and the effect is amplified in people with reactive airways. You’ll also be asked about triggers: exercise, cold air, viral infections, animals, dust, mold, pollen, strong odors, tobacco smoke, emotional stress, and weather changes. Asthma symptoms tend to flare in response to specific exposures and then improve when the exposure stops. If your symptoms follow that variable, trigger-driven pattern rather than being steadily progressive, asthma moves higher on the list of possibilities.
Your doctor will also ask about personal or family history of allergies, eczema, or hay fever. These atopic conditions run alongside asthma frequently, and their presence raises the likelihood of an asthma diagnosis. Smoking history is important too, since it helps separate asthma from COPD or overlap between the two.
Spirometry: The Core Breathing Test
Spirometry is the standard first test. You breathe in as deeply as you can, then blow out as hard and fast as possible into a mouthpiece connected to a machine. The test measures two key values: how much air you can force out in the first second (FEV1) and the total volume you can exhale (FVC). The ratio between these two numbers tells your doctor whether your airways are obstructed. A lower-than-expected FEV1/FVC ratio signals that air isn’t flowing out freely, which is the hallmark of obstructive lung conditions like asthma.
But obstruction alone doesn’t confirm asthma. What separates asthma from other obstructive conditions is reversibility. After the initial reading, you’ll inhale a short-acting bronchodilator (a medication that relaxes airway muscles) and repeat the test about 15 minutes later. If your FEV1 improves by at least 12% and at least 200 milliliters, the obstruction is considered reversible, and this is strong evidence for asthma. The American Thoracic Society and European Respiratory Society both use these thresholds as the standard definition of reversibility.
One catch: if you’re tested on a good day when your airways happen to be open, spirometry can come back completely normal. That doesn’t rule out asthma. It just means your doctor needs to look at other tests or catch you during a symptomatic period.
Peak Flow Monitoring at Home
When spirometry is normal or inconclusive, your doctor may send you home with a peak flow meter, a small handheld device you blow into to measure how fast you can push air out of your lungs. The goal is to track your readings over two to four weeks, typically measuring four times a day, to look for a pattern of variability.
The key calculation is diurnal variability: the difference between your highest and lowest reading in a day, divided by the average of those two readings, expressed as a percentage. International guidelines from GINA recommend that variability greater than 10% in adults supports an asthma diagnosis. UK guidelines set the bar higher at 20%. A practical consensus places the diagnostically significant range between 10% and 20%. If your peak flow swings by that much from morning to evening or from one day to the next, it confirms the kind of variable airflow limitation that defines asthma.
Peak flow monitoring also plays a specific role when work-related asthma is suspected. The CDC recommends recording readings four times daily on both workdays and days off over several weeks. If your numbers consistently improve when you’re away from work and worsen when you return, that pattern points toward an occupational trigger.
Bronchial Challenge Testing
If spirometry is normal and peak flow monitoring hasn’t caught enough variability, a bronchial provocation test can push your airways to reveal hidden hyperresponsiveness. The most common version is the methacholine challenge. During this test, you inhale gradually increasing concentrations of methacholine, a substance that causes airway muscles to tighten in sensitive individuals. After each dose, spirometry is repeated.
The result is expressed as the PC20: the concentration of methacholine that causes your FEV1 to drop by 20%. A PC20 of 16 mg/ml or higher falls in the normal range, meaning your airways are not overly reactive. The lower your PC20, the more sensitive your airways are. This test is particularly useful for ruling asthma out. If your airways don’t react even at high doses, asthma is very unlikely. The test does have a margin of error of about one to one and a half doubling concentrations, so results are interpreted alongside your symptoms and history rather than in isolation.
Exhaled Nitric Oxide (FeNO) Testing
FeNO testing measures the level of nitric oxide in your breath, which reflects a specific type of inflammation in your airways. You breathe steadily into a machine for about 10 seconds, and the result comes back in parts per billion (ppb). Levels above 25 to 28 ppb in adults suggest the eosinophilic airway inflammation commonly seen in asthma. One study found that FeNO levels above 28 ppb in adults with allergic rhinitis predicted the future development of asthma.
This test is helpful but not definitive on its own. Not all asthma involves this type of inflammation, and elevated FeNO can also appear in people with allergic conditions who don’t have asthma. It works best as a supporting piece of evidence alongside spirometry and your symptom history, and it can help your doctor decide which type of treatment is most likely to work for you.
Blood Tests for Asthma Phenotyping
Blood eosinophil counts and IgE levels don’t diagnose asthma directly, but they help characterize what kind of asthma you have once the diagnosis is being considered. Eosinophils are a type of white blood cell involved in allergic inflammation. A count above 300 cells per microliter (or above 3% of your white blood cells) predicts a higher risk of flare-ups and a good response to inhaled corticosteroids, the most common asthma controller medication. At a cutoff of 270 cells per microliter, blood eosinophil testing has about 90% specificity for identifying eosinophilic airway inflammation, meaning false positives are rare.
These numbers become especially relevant if your asthma turns out to be moderate or severe. Eosinophil counts at or above 150 cells per microliter help predict whether you’ll respond to biologic therapies, which are targeted treatments reserved for asthma that doesn’t respond to standard inhalers.
Ruling Out Conditions That Look Like Asthma
Several conditions produce symptoms nearly identical to asthma, and part of the diagnostic process is making sure one of them isn’t the actual cause. The most common overlap is with COPD, particularly in adults over 40 who smoke or used to smoke. The two conditions share wheezing, shortness of breath, and coughing, but they differ in important ways.
- Symptom pattern: Asthma symptoms fluctuate, often worsening at night and in response to triggers, then improving. COPD symptoms are more constant and gradually worsen over years.
- Reversibility: Asthma-related airway obstruction reverses significantly with bronchodilators. COPD obstruction reverses only partially or not at all.
- Allergy connection: Asthma is frequently linked to allergies, eczema, and hay fever. COPD typically is not.
- Smoking history: COPD almost always involves a significant smoking history (10 or more pack-years). Asthma can develop regardless of smoking status.
- Inflammation type: Asthma tends to involve eosinophil-driven inflammation, while COPD inflammation is driven primarily by neutrophils.
Heart failure is another important mimic, especially in older adults. Fluid buildup in the lungs from a failing heart causes breathlessness and wheezing that can be indistinguishable from asthma at first. A chest X-ray or heart function test typically clears this up. Vocal cord dysfunction, where the vocal cords close inappropriately during breathing, can also cause wheezing and breathlessness that doesn’t respond to asthma medications. And in nonsmoking adults with a chronic productive cough and airflow obstruction, bronchiectasis (permanent widening of the airways from repeated infections) should be considered.
What the Diagnostic Pathway Looks Like in Practice
For most adults, the diagnosis comes together over one to three visits. The first visit involves your history and spirometry with bronchodilator reversibility testing. If spirometry confirms obstruction that reverses, and your symptoms fit the pattern, you have your diagnosis. If spirometry is normal on that day, your doctor will likely send you home with a peak flow meter or schedule a return visit when you’re symptomatic. If peak flow monitoring is inconclusive, a methacholine challenge or FeNO test fills in the gap.
Some adults go years with undiagnosed asthma because they assume their coughing is from allergies or their breathlessness is from being out of shape. If you’re experiencing recurrent episodes of wheezing, chest tightness, or coughing that worsens at night or with specific triggers, the diagnostic process is straightforward and noninvasive. Spirometry takes a few minutes, peak flow monitoring is done at home, and even a methacholine challenge is typically completed within an hour.